
Descemet membrane endothelial keratoplasty (DMEK) accounts for >50% of all corneal transplants in Germany. So far, no data from such a large multicenter study have been published. Descemet membrane endothelial keratoplasty increases visual acuity with low transplant failure‐ and rejection rates. FECD has a better outcome than BK. Since a quarter of all patients need a rebubbling, this should be included in the informed consent. Remarkably, one rebubbling does not influence the outcome.
Like
Save
Share